Kristine Lewis
Physician Assistant · Warsaw, NCNPI 1598746547
Payments from drug & device makers
Across 299 payments — averaging $14.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$541
- GSK$411
- AbbVie$409
- Eisai Inc.$289
- Lilly USA, LLC$281
- Novo Nordisk$269
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,37599%
- Education$271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 26 | $541 |
| GSK | 32 | $411 |
| AbbVie | 38 | $409 |
| Eisai Inc. | 26 | $289 |
| Lilly USA, LLC | 18 | $281 |
| Novo Nordisk | 19 | $269 |
| Bayer | 14 | $262 |
| Merck | 17 | $250 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $208 |
| Mylan Specialty L.p. | 9 | $166 |
| Ironwood Pharmaceuticals, Inc | 10 | $152 |
| Esperion Therapeutics, Inc. | 6 | $104 |
| Sanofi-aventis U.S. LLC | 6 | $94 |
| Pfizer | 5 | $93 |
| Amarin Pharma, Inc. | 6 | $76 |
| Xeris Pharmaceuticals, Inc. | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $69 |
| Abbott | 3 | $64 |
| Biohaven Pharmaceuticals, Inc. | 4 | $61 |
| Amgen | 4 | $49 |
| Azurity Pharmaceuticals, Inc. | 3 | $49 |
| Arbor Pharmaceuticals, Inc. | 3 | $47 |
| Boehringer Ingelheim | 3 | $41 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Almatica Pharma LLC | 2 | $34 |
| Ardelyx, Inc. | 2 | $31 |
| Avanir Pharmaceuticals, Inc. | 2 | $31 |
| Sunovion Pharmaceuticals Inc. | 3 | $29 |
| Idorsia Pharmaceuticals US Inc | 2 | $28 |
| Novartis | 2 | $26 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| Corium, LLC | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Johnson & Johnson | 1 | $12 |
How this compares
$4,402 in reported general payments places this provider in the 90th percentile of 7,441 physician assistant providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 204 | $268,989 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 141 | $186,670 |
| RybelsusSemaglutide | 112 | $168,839 |
| FarxigaDapagliflozin Propanediol | 178 | $147,783 |
| LinzessLinaclotide | 99 | $104,290 |
| JardianceEmpagliflozin | 87 | $85,602 |
| EliquisApixaban | 75 | $71,659 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 38 | $59,633 |
| KerendiaFinerenone | 49 | $50,792 |
| TrulicityDulaglutide | 21 | $39,228 |
| JanuviaSitagliptin Phosphate | 31 | $30,598 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 44 | $28,671 |
| TrintellixVortioxetine Hydrobromide | 41 | $26,660 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 23 | $25,380 |
| MyrbetriqMirabegron | 25 | $21,187 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $269 | $437,827316 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $411 | $217,539178 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $541 | $164,476200 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta | $41 | $162,893152 claims |
| AbbVieLinzess | $409 | $104,29099 claims |
| MerckJanuvia, Janumet Xr, Belsomra | $250 | $76,069113 claims |
| PfizerEliquis | $93 | $71,65975 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $281 | $55,70036 claims |
| BayerKerendia | $262 | $50,79249 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $69 | $26,66041 claims |
| Johnson & JohnsonXarelto | $12 | $16,03911 claims |
| Esperion Therapeutics, Inc.Nexlizet | $104 | $14,55016 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Warsaw
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
- Jay ClarkeArden$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.